We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Event has ended: Unfortunately you are too late to attend this event because it has already passed.

Recent and Upcoming BPCIA Guidance from the Federal Circuit and the Supreme Court

Fish & Richardson PC

23 May 2017


Event Details

Tue, May 23, 2017 6:00 PM - 7:00 PM BST

The Federal Circuit and the Supreme Court are poised to issue new guidance on the BPCIA governing the abbreviated pathways for biosimilars. In our upcoming webinar, John Adkisson, Tasha Francis, and Jenny Shmuel will provide an overview of the pending issues and the potential ramifications for the biologic and biosimilar industries.

You will learn about the issues pending before these courts, including:

Updates in the ongoing dispute as to whether the "patent dance" is optional 

The contours of the “Notice of Commercial Marketing” requirement.

The scope of discovery in a BPCIA litigation.

The weight accorded to materials exchanged in the “patent dance” in an infringement determination.

If you are interested in keeping up to date with biosimilars issues, this complimentary webinar is for you.